Artificial Saliva in Diabetic Xerostomia (ASDIX): Double Blind Trial of Aldiamed(®) Versus Placebo

Xerostomia is a symptom frequently present in patients with type 1 (T1DM) and type 2 diabetes mellitus (T2DM). In the present trial, the activity of an artificial saliva (aldiamed(®) spray) in comparison to a placebo spray were used to evaluate the xerostomia and the saliva antioxidant capacity (SAT...

Descripción completa

Detalles Bibliográficos
Autores principales: Sinjari, Bruna, Feragalli, Beatrice, Cornelli, Umberto, Belcaro, Giovanni, Vitacolonna, Ester, Santilli, Manlio, Rexhepi, Imena, D’Addazio, Gianmaria, Zuccari, Francesca, Caputi, Sergio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408818/
https://www.ncbi.nlm.nih.gov/pubmed/32664567
http://dx.doi.org/10.3390/jcm9072196

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408818/
https://www.ncbi.nlm.nih.gov/pubmed/32664567
http://dx.doi.org/10.3390/jcm9072196

Ejemplares similares